Showing results (381-390 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|May 19, 2022
Standard and reference-based conditional mean imputationMarcel Wolbers, Alessandro Noci, Paul Delmar, et al.Pharmaceutical Statistics|September 30, 2017
Antibiotics to outpatients in Norway-Assessing effect of latitude and municipality population size using quantile regression in a cross-sectional studyPål Haugen, Gunnar S Simonsen, Raul Primicerio, et al.Pharmaceutical Statistics|April 28, 2023
Combining evidence from clinical trials in conditional or accelerated approvalManja Deforth, Charlotte Micheloud, Kit C Roes, et al.Pharmaceutical Statistics|June 25, 2019
Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinicB Clare Lendrem, Dennis W Lendrem, Arthur G Pratt, et al.Pharmaceutical Statistics|September 15, 2018
A practical guide to pre-trial simulations for Bayesian adaptive trials using SAS and BUGSChristian Holm Hansen, Pamela Warner, Allan Walker, et al.Pharmaceutical Statistics|July 28, 2018
Points to consider for analyzing efficacy outcomes in long-term extension clinical trialsBohdana Ratitch, Ilya Lipkovich, Janelle Shannon Erickson, et al.Pharmaceutical Statistics|May 5, 2017
Coping with missing data in phase III pivotal registration trials: Tolvaptan in subjects with kidney disease, a case studyJohn Ouyang, Kevin J Carroll, Gary Koch, et al.Pharmaceutical Statistics|May 5, 2018
Design and inference for 3-stage bioequivalence testing with serial sampling dataFangrong Yan, Huihong Zhu, Junlin Liu, et al.Pharmaceutical Statistics|September 2, 2016
A novel approach to estimation of the time to biomarker threshold: applications to HIVTarylee Reddy, Geert Molenberghs, Edmund Njeru Njagi, et al.Pharmaceutical Statistics|September 24, 2016
Implementation of pattern-mixture models in randomized clinical trialsP Bunouf, G MolenberghsPageof 119